Polar Asset Management Partners’s United Therapeutics UTHR Stock Holding History

Polar Asset Management Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,100	Closed	-$7.8M	–	744
2024 Q4	$7.8M	Buy	+22,100	New	+$8.12M	0.09%	189
2023 Q1	–	Sell	-138,500	Closed	-$38.5M	–	1164
2022 Q4	$38.5M	Sell	138,500 -8,800	-6%	-$2.22M	0.47%	24
2022 Q3	$30.8M	Buy	147,300 +65,900	+81%	+$14.7M	0.37%	33
2022 Q2	$19.2M	Buy	81,400 +21,300	+35%	+$4.33M	0.22%	110
2022 Q1	$10.8M	Sell	60,100 -2,900	-5%	-$552K	0.12%	222
2021 Q4	$13.6M	Sell	63,000 -24,000	-28%	-$4.71M	0.14%	168
2021 Q3	$16.1M	Buy	87,000 +32,000	+58%	+$6.3M	0.16%	153
2021 Q2	$9.87M	Buy	+55,000	New	+$10.5M	0.1%	223

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Polar Asset Management Partners's UTHR Position: Q1 2025 in Review

Polar Asset Management Partners sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 22,100 shares — an estimated $7.8M sold.

Polar Asset Management Partners first reported a position in UTHR in Q2 2021 and held it in 8 quarters. The position peaked at $38.5M in Q4 2022. 673 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

Polar Asset Management Partners reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
Polar Asset Management Partners sold 22,100 United Therapeutics shares in Q1 2025, an estimated $7.8M.
Polar Asset Management Partners first reported a position in United Therapeutics in Q2 2021 and held it in 8 quarters.
Polar Asset Management Partners's United Therapeutics position peaked at $38.5M in Q4 2022.
673 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.